Trial Profile
Placebo controlled fMRT assessment of the effects of the cannabinoid receptor agonist dronabinol (THC) on pain associated brain activation
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 28 May 2019
Price :
$35
*
At a glance
- Drugs Dronabinol (Primary)
- Indications Acute pain
- Focus Pharmacodynamics
- 06 Jul 2012 Status changed from recruiting to completed as reported by German Clinical Trials Register.
- 06 Sep 2011 New trial record